Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanoxis Consulting is a private Swedish proteomics and contract research company focused on mass spectrometry-based analysis of membrane proteins, microbial surfaces, and extracellular vesicles. The company provides research services rather than developing therapeutic drug candidates, with particular expertise in surfaceome analysis, surface shaving of intact bacteria, epitope identification, and microbial characterization. Its core enabling technology is the LPI (lipid-based protein immobilization) platform, which is used to study native proteins and membrane-associated biology. Nanoxis Consulting works with both academic groups and industrial partners on fee-for-service and collaborative projects. The company appears to be commercially active and generating revenue from proteomics services and platform-enabled research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoxis Consulting.